Siemens Healthineers Ag Stock Performance
| SMMNY Stock | USD 26.83 0.26 0.98% |
The entity has a beta of 0.32, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Siemens Healthineers' returns are expected to increase less than the market. However, during the bear market, the loss of holding Siemens Healthineers is expected to be smaller as well. At this point, Siemens Healthineers has a negative expected return of -0.11%. Please make sure to validate Siemens Healthineers' coefficient of variation, value at risk, as well as the relationship between the Value At Risk and rate of daily change , to decide if Siemens Healthineers performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Siemens Healthineers AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 1.3 B | |
| Total Cashflows From Investing Activities | -868 M |
Siemens |
Siemens Healthineers Relative Risk vs. Return Landscape
If you would invest 2,907 in Siemens Healthineers AG on August 30, 2024 and sell it today you would lose (224.00) from holding Siemens Healthineers AG or give up 7.71% of portfolio value over 90 days. Siemens Healthineers AG is currently producing negative expected returns and takes up 1.6101% volatility of returns over 90 trading days. Put another way, 14% of traded pink sheets are less volatile than Siemens, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Siemens Healthineers Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Siemens Healthineers' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Siemens Healthineers AG, and traders can use it to determine the average amount a Siemens Healthineers' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0711
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SMMNY |
Estimated Market Risk
| 1.61 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Siemens Healthineers is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Siemens Healthineers by adding Siemens Healthineers to a well-diversified portfolio.
Siemens Healthineers Fundamentals Growth
Siemens Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Siemens Healthineers, and Siemens Healthineers fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Siemens Pink Sheet performance.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0383 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 59.39 B | |||
| Shares Outstanding | 2.24 B | |||
| Price To Earning | 28.75 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 2.66 X | |||
| Revenue | 21.71 B | |||
| EBITDA | 4.26 B | |||
| Cash And Equivalents | 1.37 B | |||
| Cash Per Share | 0.61 X | |||
| Total Debt | 15 M | |||
| Debt To Equity | 0.85 % | |||
| Book Value Per Share | 8.39 X | |||
| Cash Flow From Operations | 2.5 B | |||
| Earnings Per Share | 0.97 X | |||
| Total Asset | 49.06 B | |||
About Siemens Healthineers Performance
Evaluating Siemens Healthineers' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Siemens Healthineers has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Siemens Healthineers has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft. SIEMENS HEALTHINEERS is traded on OTC Exchange in the United States.Things to note about Siemens Healthineers performance evaluation
Checking the ongoing alerts about Siemens Healthineers for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Siemens Healthineers help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Siemens Healthineers generated a negative expected return over the last 90 days | |
| Latest headline from thelincolnianonline.com: Bluejay Diagnostics Implements 1-for-50 Reverse Stock SplitBluejay Diagnostics, Inc. recently announced a significant development in its corporate structure with the completion of a reverse stock split. The decision for the reverse sto |
- Analyzing Siemens Healthineers' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Siemens Healthineers' stock is overvalued or undervalued compared to its peers.
- Examining Siemens Healthineers' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Siemens Healthineers' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Siemens Healthineers' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Siemens Healthineers' pink sheet. These opinions can provide insight into Siemens Healthineers' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Siemens Pink Sheet Analysis
When running Siemens Healthineers' price analysis, check to measure Siemens Healthineers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Siemens Healthineers is operating at the current time. Most of Siemens Healthineers' value examination focuses on studying past and present price action to predict the probability of Siemens Healthineers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Siemens Healthineers' price. Additionally, you may evaluate how the addition of Siemens Healthineers to your portfolios can decrease your overall portfolio volatility.